# Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean

> **NCT03574415** · PHASE1 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 80 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** DWP14012
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03574415
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2019-01-18
- **Final completion:** 2019-01-23
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03574415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03574415, "Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03574415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*